LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

LENSAR, Inc.

Bookimed provides a platform for patients to find and connect with doctors specializing in laser eye surgery. The service includes online consultations and assistance in selecting medical specialists and clinics.

Evgeniy Kozlov

Bookimed

Vision Laser specializes in refractive surgery, primarily addressing myopia and other visual defects. They provide treatment for age-related macular degeneration (DMLA) and offer a comprehensive approach to managing various eye conditions.

Vision Laser

LENSAR designs and develops laser systems for cataract treatment and offers solutions aimed at improving outcomes and efficiency in eye surgeries. Self-described as a premier cataract treatment platform.

Metric
Company Name	LENSAR, Inc.	Bookimed	Vision Laser
Symbol	LNSR
MSH ID	COM:LENSAR	COM:BOOKIMED:US-UK	FR:VISION-LASER
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Devices	Medical Services	Ophthalmology
Country	US	US	FR
Stage		Seed
Employee Count	130
Website	lensar.com	us-uk.bookimed.com/doctors	vision-laser.fr
LinkedIn		bookimed
Founders

Metric
Market Cap	51.86M
Enterprise Value
Monthly Web Traffic		691.38K
Web Traffic Growth		0.21
Valuation
Raised Capital		500K

Metric
Revenue	42.16M
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.01M
EBITDA	-8.71M
Operating Income	-12.23M
Net Income	-14.38M
EPS	-1.31
Diluted EPS	-1.31
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.50
Operating Profit Margin	-0.21
EBITDA Margin	-0.21
Net Profit Margin	-0.28
Return on Equity	-0.30
Return on Assets	-0.19
Return on Capital Employed	-0.18

COM:LENSAR

LENSAR

Last Close

7.45

22/11 21:00

Market Cap

51.86M

Beta: -

Volume Today

66.91K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-3.08
P/B Ratio	1.17
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.49
EV Multiple	-3.75

Metric
Days Sales Outstanding	37.25
Days Payables Outstanding	80.48
Days Inventory Outstanding	291.32
Operating Cycle	335.18
Cash Conversion Cycle	270.90
Asset Turnover	0.73

Metric
Operating Cash Flow	-9.66M
Free Cash Flow	-9.89M
Cash Flow to Debt	-0.43
Operating Cash Flow/Sales	-0.14
Free Cash Flow Yield	-0.33

Metric
Cash & Equivalents	20.62M
Accounts Receivable	1.08M
Inventory	15.69M
Goodwill
Debt to Capitalization	0.38
Debt to Assets	0.03
Current Ratio	4.42
Quick Ratio	2.44

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.16
R&D to Revenue	0.16
SG&A to Revenue